As the global markets brace for another tumultuous week, the interplay between geopolitical tensions and sector-specific dynamics is shaping the investment landscape. The escalation in US-Iran tensions has injected a dose of volatility into the markets, with investors closely monitoring the potential for further disruptions in oil supplies. This geopolitical uncertainty is exacerbating inflationary pressures, which are already a significant concern for central banks worldwide. The Federal Reserve, in particular, is under scrutiny as it navigates the delicate balance between curbing inflation and supporting economic growth. Recent inflation data has heightened fears of a more aggressive monetary tightening, with the possibility of a half-point rate hike in December looming large. In this environment, sector-specific rotations are becoming increasingly pronounced. The airline industry, already battered by the pandemic's lingering effects, faces additional headwinds from rising fuel costs and geopolitical risks. Investors are cautious, with many opting for defensive plays amid the uncertainty. Meanwhile, the semiconductor sector is experiencing a resurgence, driven by the ongoing demand for AI and tech infrastructure. Companies like CoreWeave have captured investor attention, benefiting from the AI boom despite broader market jitters. However, the recent scandal at Nvidia, involving its CEO Jensen Huang, has cast a shadow over the sector, raising questions about leadership stability and its impact on the broader AI trade. Energy stocks are also in the spotlight, with oil prices fluctuating in response to geopolitical developments and supply concerns. The potential for further disruptions in the Middle East could drive prices higher, benefiting energy companies but also stoking inflation fears. This dynamic underscores the complex relationship between geopolitical events and market performance, with energy prices acting as a critical barometer for broader economic conditions. On the corporate front, Bristol Myers Squibb stands out as a beacon of resilience. Despite the market's volatility, the healthcare giant's stock has surged, reflecting investor confidence in its growth prospects and strategic positioning. Trading at 10 times forward earnings, Bristol Myers Squibb exemplifies the potential for strong fundamentals to shine through even in uncertain times. As the markets navigate these multifaceted challenges, the interplay between macroeconomic forces and corporate developments will continue to shape the investment landscape. Investors are advised to remain vigilant, balancing the pursuit of growth opportunities with the need for risk management in an increasingly unpredictable environment.
Companies Reporting Earnings Today
| Symbol | Price | Change | MarketCap |
|---|---|---|---|
| CSCO | 100.7600 | 2.66% | 397255053323 |
| AMAT | 395.0800 | 6.05% | 313534477780 |
| BN | 42.0600 | -0.78% | 93892706277 |
| BPYPN | 13.5601 | -0.22% | 93892706270 |
| ATH-PA | 22.3600 | 0.04% | 72607261842 |
| NU | 12.3200 | 1.99% | 59514085375 |
| NBIS | 154.6900 | 15.44% | 37125600000 |
| EC | 15.3000 | 0.26% | 31454271476 |
| CBRS | 101.0800 | 7.92% | 22897911872 |
| ASND | 259.2800 | 1.05% | 17061568298 |
| KEP | 11.3900 | 1.61% | 14623939920 |
| QXO | 13.8100 | 0.58% | 14327736900 |
| BNT | 42.0700 | -0.59% | 13993876158 |
| WSE | 11.1500 | 0.90% | 11152950290 |
| FRHC | 163.7200 | -1.06% | 10443316678 |
| HBM | 21.9400 | -0.05% | 9744536034 |
| CIG-C | 3.0200 | 0.33% | 8639259821 |
| STN | 75.5000 | -0.44% | 8486200000 |
| TWST | 122.5900 | -7.22% | 8070393916 |
| DDS | 642.2900 | 0.01% | 7617256239 |
| ANDG | 65.8400 | 0.11% | 7406061780 |
| ARWR | 49.3600 | 0.73% | 6972297440 |
| KOD | 109.3400 | 1.18% | 6871959628 |
| BPYPO | 14.7000 | -0.94% | 6566511756 |
| BPYPP | 15.1200 | -1.39% | 6343342241 |
| BLTE | 155.9400 | -0.37% | 6280038135 |
| NIQ | 21.0600 | 0.19% | 6211770622 |
| MBGL | 19.9200 | -0.05% | 5872840694 |
| CIG | 1.9000 | 1.60% | 5435295743 |
| HTFL | 59.1000 | 5.91% | 5138959356 |
| LGN | 37.0900 | 15.73% | 5126728716 |
| AVAL | 4.2100 | -5.39% | 4998001660 |
| ATH-PE | 24.4400 | -0.08% | 4980872000 |
| FIGR | 24.1900 | 3.64% | 4491409309 |
| DPC | 31.6500 | 5.89% | 4461700500 |
| ARX | 19.8700 | -0.20% | 4315536369 |
| DLO | 13.9600 | -0.21% | 4107997097 |
| SKE | 30.5700 | -2.61% | 3835394892 |
| PBLS | 29.6500 | -1.23% | 3615877690 |
| AYA | 24.4900 | -2.70% | 3527441640 |
| MWH | 27.5800 | 0.58% | 3412898132 |
| ONDS | 5.7300 | 2.87% | 3336594465 |
| ATH-PB | 15.9600 | -1.39% | 3252648000 |
| CLBT | 12.7000 | 0.47% | 3192030700 |
| LFTO | 18.5500 | 1.70% | 3141099826 |
| YETI | 42.7900 | -4.42% | 3123190752 |
| AVAH | 13.0900 | -0.76% | 2857425040 |
| ATH-PD | 13.8300 | -0.58% | 2818554000 |
| DAC | 150.8500 | 2.45% | 2746013060 |
| ATAI | 7.3500 | 0.00% | 2725855317 |
| SEAL-PA | 25.0800 | 0.32% | 2505474745 |
| LUNR | 12.1800 | 3.13% | 2472383183 |
| PHVS | 34.1800 | 0.56% | 2399589810 |
| SEAL-PB | 24.9300 | 1.84% | 2169059580 |
| ELPC | 10.9600 | 1.67% | 2034183168 |
| SPB | 88.2900 | -0.45% | 2030281524 |
| DRVN | 11.9600 | -1.16% | 1973158599 |
| WWW | 21.9300 | 1.11% | 1799713959 |
| STNE | 7.8500 | 2.35% | 1799039450 |
| INTR | 4.0300 | 1.77% | 1779299324 |
| ABSI | 10.1200 | 1.50% | 1736733680 |
| GENB | 13.4900 | -2.10% | 1731474281 |
| HAWK | 15.2600 | 1.94% | 1494954293 |
| HUBG | 24.3900 | -0.25% | 1477512225 |
| ARCO | 6.9400 | 1.02% | 1462001657 |
| EYE | 18.0900 | -4.84% | 1430363872 |
| ACCV | 11.9100 | 11.52% | 1429467642 |
| KARD | 15.6800 | 3.29% | 1400837417 |
| TSHA | 4.2800 | 0.12% | 1390405080 |
| ADIG | 19.5700 | 2.62% | 1352882593 |
| EPC | 29.1500 | -1.55% | 1343491435 |
| FLO | 6.2500 | -3.10% | 1325356250 |
| GHRS | 19.2500 | -1.58% | 1321364025 |
| GDRX | 3.6500 | 3.11% | 1245180670 |
| AIIR | 7.5800 | 0.13% | 1215730428 |
| SGP | 34.9700 | 2.31% | 1169675826 |
| SPH | 17.6100 | -0.56% | 1168301234 |
| SCCD | 24.9001 | -0.12% | 1167196844 |
| FRMI | 1.8100 | 17.53% | 1160680057 |
| SCCF | 24.2500 | 0.00% | 1156509175 |
| SCCG | 24.1645 | 0.10% | 1152431586 |
| SCCE | 24.4746 | 0.43% | 1147251452 |
| JCAP | 19.9400 | 1.42% | 1145065208 |
| NKTR | 38.4400 | 1.75% | 1102765298 |
| SID | 0.8294 | 2.36% | 1099862320 |
| TMC | 2.4550 | 1.45% | 1082987608 |
| JBIO | 16.5400 | 0.85% | 1051900781 |
| AZUL | 4.9500 | -6.95% | 992052349 |
| AFYA | 10.7300 | 2.09% | 981286634 |
| KPLT | 11.1800 | -2.95% | 948612938 |
| SLN | 19.7700 | -0.10% | 933815152 |
| ORIC | 9.0000 | 1.01% | 932873904 |
| MGTX | 9.6800 | 0.62% | 929696201 |
| AKTS | 17.0400 | -2.35% | 915843257 |
| BZH | 33.4800 | 0.09% | 893233778 |
| ALMS | 6.6200 | 3.44% | 856861282 |
| YSWY | 25.6500 | -0.50% | 799909640 |
| PRME | 4.3000 | 10.26% | 779920481 |
| MTA | 7.7100 | -3.99% | 720853189 |
| CADL | 9.2200 | -1.39% | 705501169 |
| NMAX | 7.7400 | 2.52% | 695991234 |
| CSIQ | 10.1700 | 0.30% | 690509439 |
| TE | 2.1300 | 2.90% | 637932610 |
| BRUN | 7.3800 | 15.49% | 586617337 |
| WHK | 25.4500 | 2.37% | 585262936 |
| VINP | 8.8700 | 3.02% | 582326712 |
| HELP | 9.3900 | 3.53% | 582030699 |
| SSYS | 6.5400 | -0.30% | 576060858 |
| NFEGP | 223.2500 | -2.93% | 548064462 |
| CBIO | 14.7550 | 6.00% | 548058835 |
| DMAC | 9.6600 | -0.10% | 520922233 |
| NEXN | 9.0500 | 2.03% | 515410451 |
| CTGO | 14.4300 | -5.13% | 482549171 |
| MNPR | 71.7300 | -0.07% | 481463954 |
| CMDB | 19.7900 | 2.75% | 480926487 |
| BCSS | 10.2300 | 0.10% | 479787000 |
| RLMD | 4.4300 | 3.75% | 472547418 |
| UAMY | 3.1200 | -2.80% | 466967280 |
| ALLT | 8.9700 | 2.16% | 442248753 |
| BAK | 1.1000 | -0.90% | 438332608 |
| NPCE | 12.5200 | -1.34% | 429739910 |
| GLOP-PB | 25.8900 | -0.12% | 415187600 |
| BOC | 13.7400 | 0.66% | 413938989 |
| CRMD | 5.3000 | -1.30% | 413104790 |
| GLOP-PC | 25.3200 | -0.22% | 406046737 |
| GLOP-PA | 25.1000 | -0.16% | 402518710 |
| VGZ | 2.7300 | -1.97% | 398500830 |
| DDL | 1.8200 | 5.20% | 397955968 |
| CDROW | 0.0189 | 26.00% | 394451513 |
| CDRO | 8.6750 | 1.34% | 394451513 |
| CMCL | 20.0000 | -4.53% | 386701580 |
| ALT | 1.9300 | -0.52% | 375419163 |
| FENC | 10.6400 | 0.57% | 373114561 |
| SGMT | 11.4100 | 4.78% | 371758304 |
| SPCE | 2.8700 | 2.87% | 368901979 |
| EIKN | 6.6700 | 8.81% | 361104649 |
| WSBF | 20.0800 | -0.40% | 360978722 |
| SLI | 1.4600 | -5.81% | 360304640 |
| PSFE | 6.8200 | -4.21% | 356109519 |
| LWAY | 22.5100 | 1.12% | 340052875 |
| SHIP | 15.4200 | 5.33% | 334115903 |
| CV | 6.2700 | -1.57% | 333628938 |
| GEMI | 2.7200 | 2.64% | 332330810 |
| CDZIP | 19.4000 | -1.65% | 330010141 |
| SES | 0.9000 | 1.50% | 329995931 |
| CHAD | 10.0000 | 0.00% | 326207900 |
| FTW | 10.1800 | 1.09% | 320662233 |
| IPSC | 1.7400 | 3.57% | 315071059 |
| SSII | 1.5100 | -6.21% | 302721780 |
| ASPI | 1.9600 | -1.01% | 300486385 |
| MLP | 15.1100 | 1.41% | 300072512 |
| MPTI | 67.2200 | 4.31% | 292170117 |
| KPET | 10.0000 | 0.00% | 289850000 |
| CDZI | 3.3800 | 1.50% | 287367127 |
| BTBT | 0.7948 | 8.77% | 286631508 |
| FULC | 3.7400 | 0.54% | 285351737 |
| LRMR | 2.7300 | 1.49% | 283600590 |
| LCTX | 1.1100 | 6.73% | 280726770 |
| NUAI | 2.3300 | 12.56% | 273289288 |
| RCKT | 2.4800 | 1.22% | 272241001 |
| OPTX | 6.6000 | 22.00% | 265847195 |
| BMM | 3.4300 | 0.00% | 264764787 |
| BKTI | 69.4400 | 1.71% | 261746372 |
| SVIA | 2.8700 | 2.87% | 259946014 |
| HQI | 18.2500 | 2.01% | 253675000 |
| KLC | 2.1400 | -3.17% | 253626451 |
| RMR | 15.7500 | -0.13% | 253263560 |
| RCMT | 34.8200 | 1.13% | 247596628 |
| XE | 10.9400 | -0.27% | 240120069 |
| AENT | 4.5900 | -2.55% | 233996364 |
| CDR-PC | 16.7400 | 3.02% | 229642149 |
| CDNL | 14.9900 | 2.67% | 229241350 |
| TROO | 1.8300 | -7.11% | 223552800 |
| PRLD | 3.7800 | 0.53% | 218785909 |
| LIEN | 9.1700 | 0.00% | 209264902 |
| SJT | 4.4800 | 6.16% | 208807424 |
| ABAT | 1.3350 | 1.14% | 190341307 |
| TII | 1.9000 | -2.56% | 188062570 |
| IMPPP | 25.6500 | -0.57% | 181955611 |
| PED | 13.6200 | 2.10% | 181037217 |
| SBMT | 6.1200 | -1.45% | 180714420 |
| MOVE | 5.7000 | 14.92% | 179847968 |
| MDWD | 13.8200 | -2.06% | 178420042 |
| PRQR | 1.2600 | -3.82% | 177809980 |
| IVVD | 0.5993 | 4.33% | 176648916 |
| AIRJW | 0.3537 | 4.21% | 173833324 |
| AIRJ | 2.3700 | -0.42% | 173833324 |
| DMRC | 7.6800 | -3.88% | 173172104 |
| NEOV | 2.9300 | -1.35% | 172908808 |
| GDEV | 9.5400 | 12.23% | 172862644 |
| AIRO | 5.4600 | -2.50% | 172295307 |
| ORMP | 4.1300 | 4.03% | 171797072 |
| VUZI | 2.0300 | 4.10% | 171360826 |
| STRO | 10.2600 | 0.88% | 170122814 |
| IMPP | 4.4700 | 3.00% | 168033634 |
| YARW | 18.0500 | 16.60% | 167943716 |
| FUFUW | 0.0887 | -7.60% | 161187824 |
| TONT | 10.9700 | -0.09% | 155331163 |
| ALXO | 1.1200 | 0.90% | 154870237 |
| USBC | 0.3910 | 6.34% | 151774394 |
| MGNX | 2.3200 | -4.13% | 147784434 |
| SRG-PA | 20.2900 | -0.54% | 146044803 |
| NGEN | 1.3500 | 1.50% | 145155555 |
| GCTS | 1.5900 | 9.66% | 144631187 |
| FUFU | 0.8605 | 2.29% | 143405418 |
| LFMDP | 20.9000 | -0.05% | 142513735 |
| ALMU | 7.2100 | -1.90% | 139260588 |
| GUNN | 8.1000 | 1.25% | 139064534 |
| CLLS | 1.3800 | 24.32% | 139011247 |
| RNA | 7.9600 | -3.28% | 136160918 |
| MENS | 1.7400 | -2.79% | 132288135 |
| GPRO | 0.6882 | -18.34% | 129680279 |
| DEFT | 0.3322 | 8.21% | 128924495 |
| DERM | 4.4400 | 0.45% | 125316309 |
| SPMC | 5.9000 | 2.08% | 124247073 |
| CRDL | 1.0100 | -0.98% | 121866600 |
| IMUX | 8.1200 | 1.00% | 110793064 |
| SMID | 20.8600 | -3.02% | 110654165 |
| LGCY | 8.6000 | 0.12% | 110211950 |
| ENHA | 8.0500 | 3.87% | 110137178 |
| FLNT | 3.4600 | -6.99% | 109360518 |
| SSTI | 8.2300 | -0.48% | 108969315 |
| CDXS | 0.9764 | -2.36% | 106921429 |
| PARK | 22.0700 | 2.65% | 104949074 |
| EP | 2.4600 | 1.65% | 102341658 |
| VANI | 1.1300 | -1.74% | 101929792 |
| NOEM | 10.5000 | -0.19% | 100650375 |
| AGPU | 8.8400 | 15.71% | 100642870 |
| CEPL | 3.0800 | 0.65% | 100443694 |
| NBP | 0.8610 | 0.10% | 99244072 |
| SKYX | 0.7154 | 2.94% | 98799602 |
| MRLN | 1.0100 | 6.11% | 97489293 |
| PLYX | 1.9500 | 4.28% | 97199686 |
| SHIM | 2.2700 | -0.87% | 93832318 |
| FURY | 0.4926 | -2.46% | 93659119 |
| ICCC | 10.1900 | -0.68% | 92547587 |
| BUDA | 7.2000 | -1.50% | 90479995 |
| EQ | 1.4200 | -2.41% | 90039478 |
| PAL | 3.1700 | -1.86% | 88927766 |
| NMRA | 0.4730 | 1.37% | 88874761 |
| CBUS | 1.1600 | 1.31% | 88657598 |
| FLYX | 1.0900 | -1.80% | 87949555 |
| LUD | 3.8600 | -2.28% | 87583400 |
| SRG | 1.5300 | -3.16% | 86176649 |
| ANNA | 2.1000 | -2.33% | 85974000 |
| LFMD | 1.7800 | 2.30% | 85895390 |
| CPBI | 20.5100 | 0.00% | 85572560 |
| NTWK | 6.8900 | -1.57% | 82353194 |
| WFCF | 15.9900 | -1.90% | 79624811 |
| FEAM | 1.8700 | 3.31% | 77880584 |
| AMPG | 2.5500 | 3.24% | 76824870 |
| CRT | 12.5000 | -0.79% | 75000000 |
| NPWR | 0.8321 | -0.37% | 73624775 |
| LUCD | 0.3814 | -4.65% | 72827846 |
| VATE | 5.2700 | 3.13% | 71892813 |
| BWEN | 2.9800 | 0.68% | 70498972 |
| EVTL | 0.4160 | 0.97% | 70154626 |
| MNOV | 1.4100 | 0.71% | 69401957 |
| ROC | 3.5500 | 4.72% | 67734454 |
| CING | 4.6400 | 1.75% | 67474073 |
| GAMB | 1.9100 | 1.06% | 67320192 |
| ACRV | 1.5700 | 0.00% | 67279778 |
| VRCA | 3.9100 | 11.08% | 67169053 |
| NSTR | 2.8200 | 2.17% | 66721200 |
| RSSS | 1.9400 | 7.18% | 65499578 |
| HMR | 1.1050 | -7.92% | 65186157 |
| PODC | 2.1500 | 0.23% | 65043294 |
| INVE | 2.6600 | 0.00% | 64467103 |
| SLSN | 0.9110 | 4.72% | 64359458 |
| RDI | 1.8300 | 0.55% | 64003836 |
| ZTEK | 0.4920 | -12.46% | 62297040 |
| ZSTK | 2.7900 | 10.28% | 60814255 |
| NUAIW | 1.0600 | 10.69% | 60709127 |
| WYY | 6.0300 | -1.15% | 60289478 |
| CRDF | 0.7653 | -3.71% | 59536667 |
| SPRO | 1.0200 | 0.99% | 59399496 |
| PVL | 1.7700 | 0.00% | 58410000 |
| PDSB | 1.0200 | -0.97% | 56931966 |
| SRTS | 3.4100 | 3.33% | 56135621 |
| TLPH | 1.0500 | 0.00% | 54501086 |
| SPCB | 8.6200 | -0.23% | 54137479 |
| PEW | 1.8100 | 0.00% | 53419321 |
| YTRA | 0.8301 | -4.03% | 53118247 |
| TPCS | 5.2400 | -2.06% | 52925572 |
| FJET | 0.9581 | 6.80% | 52691684 |
| RDIB | 12.2600 | 5.60% | 51433826 |
| LINK | 3.2400 | -1.82% | 51041016 |
| TACT | 4.9300 | 2.71% | 50899642 |
| BTCS | 0.9406 | 0.42% | 49955548 |
| VERI | 0.4774 | -7.30% | 48517268 |
| PLRX | 0.7776 | -1.03% | 48150467 |
| HOWL | 0.9889 | 1.95% | 48059650 |
| IDN | 2.3700 | 6.76% | 48032079 |
| PEW-WT | 0.1817 | 21.05% | 46323663 |
| SGA | 7.1200 | -1.79% | 45268889 |
| ELBM | 0.4230 | -2.53% | 45239850 |
| REKR | 0.3262 | 1.40% | 44896863 |
| ICG | 1.4550 | -1.69% | 44516303 |
| XNET | 3.4900 | 0.00% | 44490831 |
| NEXM | 1.1800 | -2.79% | 42064876 |
| HYPD | 2.7100 | 4.63% | 41077494 |
| SCWO | 2.2800 | -1.72% | 40184428 |
| SOWG | 1.9700 | -2.48% | 39596789 |
| LGL | 6.9000 | 4.55% | 39109014 |
| FRMM | 2.9500 | 4.61% | 38936897 |
| IZEA | 2.2300 | 2.76% | 38588812 |
| STEX | 0.3294 | -1.96% | 38363571 |
| LVO | 2.7800 | 3.35% | 38118773 |
| SACH-PA | 18.9000 | -1.36% | 37893744 |
| XTIA | 0.9800 | -1.81% | 37708233 |
| WKHS | 3.4400 | 0.58% | 37594332 |
| IPWR | 2.2700 | 0.44% | 37276850 |
| NSPR | 0.8000 | 2.56% | 37191294 |
| EXOZ | 4.0000 | -0.99% | 37125436 |
| PTHS | 9.3900 | 5.51% | 36919874 |
| LASE | 0.6047 | 5.02% | 36687353 |
| PHUN | 1.7700 | 1.72% | 36597051 |
| PROP | 0.3660 | 0.88% | 35769975 |
| COHN | 11.0000 | 2.90% | 35518670 |
| AETR | 1.8500 | -0.54% | 35142045 |
| AVX | 4.6700 | 15.02% | 34882037 |
| AARD | 1.5900 | 16.06% | 34796905 |
| JG | 5.8800 | 2.16% | 34523038 |
| SLND | 0.6290 | -5.13% | 34239777 |
| PMN | 3.7600 | -5.53% | 33718526 |
| RMCO | 2.1900 | 2.34% | 33228213 |
| LVLU | 11.4100 | -1.21% | 32764682 |
| GROW | 2.5700 | 0.39% | 31606364 |
| NSYS | 10.7100 | 0.19% | 30563834 |
| BHST | 1.7500 | -2.23% | 30323475 |
| GRCE | 1.8550 | -0.27% | 30188318 |
| HIT | 0.5595 | -5.76% | 29989642 |
| EYPT | 0.3566 | -11.75% | 29897807 |
| HHS | 3.9500 | 0.00% | 29444248 |
| AERT | 5.5800 | 4.69% | 29283014 |
| SPRU | 1.5200 | 5.56% | 29263323 |
| BCHT | 1.1000 | 0.00% | 28936563 |
| ODYS | 1.7100 | 0.00% | 28689221 |
| RMTI | 7.0800 | -3.15% | 28535692 |
| ZONE | 3.3100 | 21.25% | 28129092 |
| SYPR | 1.2200 | 0.83% | 28092208 |
| MLSS | 0.3097 | 6.10% | 28062248 |
| LSF | 2.5000 | 2.88% | 27982210 |
| VTSI | 2.4700 | -1.20% | 27959412 |
| PRHI | 7.3300 | 1.10% | 27458854 |
| PRHIZ | 24.0000 | -9.43% | 27458832 |
| BSEM | 1.4700 | 41.35% | 27447987 |
| BZAI | 0.1890 | 5.59% | 27407534 |
| CRWS | 2.4700 | -0.80% | 26577909 |
| BYSI | 0.6438 | 11.06% | 26472940 |
| DAIO | 2.4800 | 2.06% | 25781088 |
| PSHG | 2.0550 | -1.20% | 25548085 |
| FIEE | 2.9700 | -0.17% | 25329936 |
| PPSI | 2.2700 | 2.25% | 25195334 |
| SHPH | 5.2500 | -1.69% | 25014654 |
| XOS | 2.4000 | 4.80% | 24563635 |
| MSGM | 4.3500 | -0.68% | 23528371 |
| USEA | 2.4600 | 2.50% | 23476122 |
| BEAT | 0.4110 | 0.66% | 23159509 |
| DXLG | 0.4160 | -0.91% | 23068677 |
| LFT | 4.3300 | -1.81% | 22760212 |
| SER | 1.5000 | 4.90% | 22496250 |
| NXPL | 8.2900 | -0.72% | 22492594 |
| DRIO | 2.1250 | -11.09% | 20823895 |
| BLNE | 0.6233 | -2.78% | 20524115 |
| NFE | 3.4700 | -3.07% | 19823034 |
| BCG | 1.1300 | 5.61% | 19277913 |
| FFR | 0.8400 | -5.70% | 18836328 |
| INLX | 4.0000 | 3.63% | 17979976 |
| LOCL | 0.7645 | -2.00% | 17875157 |
| TVRD | 1.3400 | -4.96% | 17874126 |
| KTTA | 0.5320 | -7.28% | 17776486 |
| SNAL | 2.3000 | 6.98% | 17290954 |
| CIRC | 0.1888 | 6.67% | 16984448 |
| CTSO | 5.3400 | -7.93% | 16826874 |
| MRKR | 0.9501 | -0.02% | 15841112 |
| DYAI | 0.3880 | 6.01% | 15544716 |
| FGI | 7.9300 | 5.87% | 15314979 |
| LONA | 3.8800 | -3.48% | 15302825 |
| KYNB | 3.6800 | 3.08% | 14900762 |
| SST | 1.7000 | -1.73% | 14805167 |
| INV | 0.1690 | 6.89% | 14661850 |
| INTZ | 0.5860 | 5.97% | 14361074 |
| BCDA | 0.9217 | -0.91% | 13953415 |
| LHAI | 0.8405 | -7.68% | 13893465 |
| FGIWW | 0.0288 | -20.00% | 13877433 |
| GRNQ | 7.3100 | -1.75% | 13251319 |
| SMSI | 2.3200 | 4.98% | 12968522 |
| PLUR | 1.2000 | 7.14% | 12947400 |
| QNTM | 1.9400 | -3.96% | 12473333 |
| MDRR | 10.0300 | -4.48% | 12428795 |
| BBGI | 5.9700 | 1.36% | 12254918 |
| GRML | 3.9400 | -1.50% | 11861705 |
| TCRX | 0.1856 | 0.22% | 11786093 |
| NEON | 0.7010 | 1.14% | 11764828 |
| GUTS | 0.8812 | 8.70% | 11689107 |
| BTLN | 3.9100 | 6.54% | 11478352 |
| LSTA | 1.2000 | 17.65% | 10813128 |
| BENF | 0.6807 | -3.30% | 10522828 |
| LIQT | 0.3110 | 3.32% | 10246779 |
| ATER | 0.9250 | -2.63% | 10035704 |
| MTVA | 1.4400 | -3.36% | 9486865 |
| KSCP | 0.3997 | 2.49% | 9324306 |
| MSLE | 6.7500 | -2.88% | 8695647 |
| ASTC | 4.2800 | 0.23% | 8598734 |
| MARPS | 4.2300 | 0.24% | 8460000 |
| YHGJ | 3.2200 | -3.88% | 8401753 |
| VTGN | 0.1878 | 2.57% | 8333982 |
| WVVI | 1.6600 | 0.61% | 8266020 |
| MBRX | 8.1000 | 0.50% | 8256241 |
| AMS | 1.1800 | 0.00% | 7847000 |
| XCUR | 1.1100 | 2.78% | 7266054 |
| ACTU | 0.3022 | 1.75% | 7257092 |
| LTRN | 0.4810 | 3.89% | 7184012 |
| MSAI | 3.4200 | 12.13% | 6906464 |
| BZAIW | 0.0152 | -1.94% | 6786815 |
| SUNE | 2.0100 | -5.63% | 6698655 |
| ENVB | 1.4900 | -1.32% | 6669067 |
| INUV | 0.3947 | 3.84% | 6505871 |
| GAUZ | 5.4158 | -8.36% | 6190991 |
| CNSY | 0.8010 | 18.12% | 6079290 |
| MYSE | 1.1500 | -4.17% | 5975895 |
| KPRX | 1.3500 | -2.17% | 5972927 |
| SBFM | 2.7500 | -3.51% | 5839996 |
| PRSO | 0.3828 | 9.12% | 5766691 |
| ACXP | 1.0300 | -0.96% | 5726192 |
| NCNA | 0.9397 | 0.50% | 5705934 |
| DFLIW | 0.0131 | 28.43% | 5396174 |
| PCSA | 1.8700 | 0.00% | 5232709 |
| RAIN | 0.5100 | 6.23% | 5091240 |
| SNTI | 0.1572 | 11.81% | 4896057 |
| NWTG | 1.0300 | 49.28% | 4895037 |
| DSS | 0.4779 | 5.73% | 4799311 |
| PULM | 1.3100 | -2.96% | 4784493 |
| TWAV | 1.2200 | 1.67% | 4730207 |
| OGGWZ | 0.0169 | 1.20% | 4719579 |
| GWH | 0.1550 | -1.27% | 4555321 |
| GXAI | 0.4111 | 0.02% | 4543596 |
| OLB | 0.1842 | 6.29% | 4424542 |
| XBIO | 1.8662 | 3.68% | 4372843 |
| SBFMW | 0.0255 | 0.00% | 4182323 |
| CWD | 0.3977 | -1.07% | 4129976 |
| IMNN | 0.7201 | -6.48% | 4040769 |
| LIMN | 2.9400 | 6.14% | 3949029 |
| DFDVW | 0.2701 | -18.14% | 3872287 |
| CYN | 0.2513 | -1.76% | 3857023 |
| TRAW | 0.2500 | 11.11% | 3842069 |
| FLYX-WT | 0.1394 | -0.07% | 3796902 |
| DFLI | 2.0200 | 5.76% | 3782147 |
| MTR | 1.9700 | 3.68% | 3671272 |
| HYFM | 0.7472 | 3.63% | 3600996 |
| AIMD | 0.4848 | 3.30% | 3579797 |
| KALA | 0.1710 | 0.00% | 3307106 |
| XGPU | 1.9600 | -2.00% | 3292682 |
| HCTI | 4.3900 | 4.28% | 3286863 |
| SQFTP | 6.2000 | 0.00% | 2949935 |
| BCAB | 1.7350 | 31.44% | 2879319 |
| NXXT | 1.7000 | 811.53% | 2862800 |
| BEATW | 0.0034 | -34.62% | 2659735 |
| VIVS | 0.1546 | 19.47% | 2564272 |
| VNRX | 0.2036 | 10.41% | 2452227 |
| XPON | 2.5611 | 2.44% | 2441217 |
| CYAB | 0.0990 | 17.86% | 1943347 |
| CAPS | 2.0150 | -3.59% | 1861123 |
| SXTP | 0.5200 | -0.10% | 1828834 |
| ISPC | 0.7094 | -3.81% | 1786688 |
| APVO | 0.7600 | -29.63% | 1662011 |
| XRTX | 0.8900 | 4.71% | 1616738 |
| ATPC | 1.3500 | 0.00% | 1350845 |
| SNYR | 0.0905 | 0.00% | 1348439 |
| ONCO | 3.7600 | 8.36% | 1347678 |
| BOXL | 1.8400 | -2.65% | 1227385 |
| SQFTW | 0.0095 | -14.41% | 1223569 |
| SQFT | 0.8530 | 1.55% | 1223569 |
| CRIS | 0.5915 | -9.42% | 1153425 |
| BENFW | 0.0072 | 18.03% | 1147930 |
| VJET | 0.5460 | -5.86% | 1147685 |
| SOAR | 0.1989 | 3.92% | 1115879 |
| ITP | 0.0614 | 0.00% | 1041677 |
| KIDZ | 1.1700 | 2.63% | 1005972 |
| TGL | 0.1840 | 2.22% | 949421 |
| GOVX | 2.1600 | -19.28% | 909258 |
| TNON | 1.7450 | 0.29% | 866316 |
| LNAI | 0.1648 | 0.00% | 829677 |
| OPNW | 0.5360 | -17.53% | 705655 |
| LABT | 0.3950 | -5.05% | 691510 |
| MSAIW | 0.0170 | 0.00% | 633336 |
| NUWE | 5.5300 | 5.53% | 509872 |
| TMCWW | 0.0011 | -45.00% | 476993 |
| CDR-PB | 17.1038 | -4.10% | 474254 |
| MTNB | 0.9300 | -24.08% | 397183 |
| KPTI | 0.0174 | 0.00% | 394657 |
| RKDA | 0.2378 | 44.12% | 367952 |
| AMPGZ | 0.0151 | -39.36% | 331883 |
| SDST | 0.0080 | 2.56% | 324616 |
| VTAK | 0.1510 | -0.66% | 317400 |
| NVVE | 0.6000 | 0.00% | 314791 |
| HCWB | 0.8600 | -8.51% | 298971 |
| LUCYW | 0.0599 | 5.09% | 296096 |
| CDT | 0.5100 | -9.14% | 237731 |
| SMTK | 0.2600 | -0.69% | 134486 |
| CTNT | 1.6600 | 3.11% | 32712 |
| RBNE | 0.1226 | -4.74% | 21398 |
| GDEVW | 0.0004 | -86.21% | 7253 |
| TNONW | 0.0038 | -26.92% | 3924 |
6-K/8-K Form Update
LUCD
Lucid Diagnostics Inc. launched EsoGuard nationwide Medicare reimbursement, achieving record monthly test volume with 2,871 tests in October, generating $1.2 million in revenue. The company received its first Medicare payments for EsoGuard and anticipates the draft Local Coverage Determination publication as administrative backlog clears. Lucid expanded commercial coverage and announced billing milestones, including a new CPT code for EsoCheck, while strengthening its balance sheet with a $15.0 million private placement, reducing cash from $34.7 million to $18.0 million.
KYTX
Kyverna Therapeutics, Inc. has completed its Biologics License Application (BLA) submission for miv-cel in Stiff Person Syndrome (SPS) with a request for priority review. The submission is based on positive data from the KYSA-8 trial, positioning miv-cel as the first approved therapy for SPS and the first CAR-T therapy in autoimmune disease. The company reported $170.6 million in cash and equivalents for Q3 2026, while advancing its neuroimmunology franchise with ongoing trials for miv-cel in Generalized Myasthenia Gravis and Progressive Multiple Sclerosis.
BTCS
BTCS Inc. reported record gross profit of $3.5 million with an 86% gross margin for Q3 2026, surpassing its full-year target of $6 million. The company's Imperium liquidity pool grew to $41 million, with DeFi revenues increasing 133% quarter-over-quarter to $3.5 million, representing 86% of total revenues. Total assets reached $176.1 million, driven by ETH price appreciation and new DeFi borrowings, while liabilities stood at $80.0 million. BTCS expects Imperium to continue driving revenue, with plans to expand into additional networks and tokenized-equity liquidity provisioning.
ICUCW
SeaStar Medical reported a 247% increase in net revenue for QUELIMMUNE therapy to $635 thousand in Q3 2026, driven by expanded pediatric AKI treatment adoption. The company achieved nearly 75% enrollment in the NEUTRALIZE-AKI pivotal clinical trial for adult AKI patients and submitted the first module of a premarket approval application to the FDA, aiming for priority review. FDA granted Breakthrough Device Designation for SCD therapy in hyperinflammation treatment, and the company's cash reserves stood at $4.0 million as of September 30, 2026.
SKYE
Skye Bioscience, Inc. announced a unanimous verdict in its favor in a lawsuit concerning whistleblower protections and retaliation, filed by a former employee. The company is proposing an acquisition of Redx Pharma Limited, with a preliminary proxy statement filed and a definitive version to be sent to shareholders. The transaction is subject to closing conditions and risks, including potential competing proposals and regulatory approvals.
FWRG
First Watch Restaurant Group, Inc. (NASDAQ: FWRG) unveiled its strategic growth vision at its Inaugural Investor Day, targeting over 2,200 restaurants across the U.S. by 2028. The company projects annual same-restaurant sales growth of 2-4%, total revenue growth of 10-13%, and Adjusted EBITDA growth exceeding 15%, with positive free cash flow expected starting in 2027. First Watch plans to open 62 restaurants in 2026 and approximately 55 in 2027, emphasizing long-term growth and earnings potential.
EROC
ERock, Inc. reported robust third-quarter financial results, with revenue surging nearly fourfold quarter-over-quarter, driven by increased generator production and installation activity. The company achieved a positive net income of $8.9 million and Adjusted EBITDA of $12.6 million, reaffirming its 2026 guidance. ERock also began construction on a 366 megawatt generation facility for Meta and expanded manufacturing capacity by 900 MW/year, boosting run-rate capacity to 2.1 gigawatts per year by 2028.
ENVX
Enovix Corporation reported Q3'26 financial results, achieving a record non-GAAP gross margin of 34.5%, up 13.5 points. The company's revenue reached $11.0 million, marking a 38% increase from Q3'25 and 22% from Q2'26, its sixth consecutive quarter of year-over-year growth. Enovix secured a 100,000-battery purchase order from a multinational drone systems provider and received an initial production order for its MX1-B01 high-energy aerial drone cells, with deliveries expected in early 2027. Additionally, the company retired $128 million of its 4.75% Convertible Senior Notes due 2030 for approximately $81 million, capturing a $47 million market discount.
CAPS
Capstone Holding Corp. reported a 46% revenue increase to $20.0 million in the third quarter of 2026, with gross profit rising 76% to $5.7 million and operating income at $0.4 million. The company anticipates full-year 2026 revenue of approximately $70 million and gross profit of $18.6 million, with Stone Business Adjusted EBITDA projected to reach $3.2 to $3.3 million, more than tripling from $1.0 million in 2025.
ALT
Altimmune, Inc. reported third-quarter financial results for the period ended September 30, 2026, with cash, cash equivalents, and investments totaling $480 million. The company highlighted progress in its clinical development programs, including the global PERFORMA Phase 3 MASH trial and positive RECLAIM Phase 2 data in AUD. Altimmune also announced the appointment of Peter Greenleaf and Alex Howarth to its Board of Directors and relocated its corporate headquarters to Morristown, New Jersey.
VOR
Vor Biopharma Inc. secured an amended and restated license agreement with RemeGen Co., Ltd., granting exclusive rights to develop and commercialize RemeGen's telitacicept outside Greater China. In exchange, RemeGen received exclusive rights in Greater China and a non-exclusive license worldwide for manufacturing the product for use in Greater China. Vor Biopharma received a $10 million upfront payment and issued a pre-funded warrant for 2.3 million shares, subject to a 9.99% ownership cap, while assuming all development and commercialization costs in the licensed territory.
TWST
Twist Bioscience Corporation reported fiscal 2026 financial results, achieving record revenue of $459.4 million, a 22% increase over the previous year. The company's DNA Synthesis and Protein Solutions (DSPS) revenue rose 28% to $221.9 million, while gross margin improved to 52.4%. For fiscal 2027, Twist Bioscience projects revenue between $550 million and $560 million, with adjusted EBITDA expected to be positive.
DPC
DPC Holdings PLC reported record third quarter 2026 revenue of $308 million, up 39% year over year, driven by strong performance in Aerospace and IGT end markets. Adjusted EBITDA grew 56%, with significant contributions from Engine Products, particularly in North America. The company refinanced its debt with a new $325 million unsecured senior revolving credit facility, providing multi-currency borrowing capacity through September 2029, and divested Ivostud.
MWH
SOLV Energy, Inc. reported a 65% year-over-year revenue increase to $1,242 million for the third quarter ended September 30, 2026, with year-to-date revenue reaching $2,870 million, up 69%. Gross profit for the quarter was $221 million, with year-to-date results at $480 million, and Adjusted Gross Profit at $215 million, totaling $484 million year-to-date. Net income rose to $123 million, and Adjusted EBITDA was $173 million, marking 13.9% of revenue. The company completed the acquisition of ASB Energy Services for approximately $36 million in cash, net of cash acquired.
CYN
Cyngn Inc. secured a follow-on order from a Fortune 100 heavy equipment manufacturer, expanding its DriveMod technology into a new assembly-line application. The company achieved ISO 27001 certification and completed a SOC 2 Type II examination with zero exceptions, enhancing its security credentials. For the third quarter of 2026, Cyngn reported revenue of $156.5 thousand, up from $70 thousand in the same period in 2025, with total costs and expenses decreasing to $6.6 million. Unrestricted cash and short-term investments increased to $34.9 million, with no debt on the balance sheet, and total stockholders' equity reached $39 million.
KPHMW
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) has in-licensed KIO-401, a late-stage oral neuroprotective calpain inhibitor, from Senju Pharmaceutical Co., Ltd., supported by Phase 2 and Phase 3 clinical data from Japan. The company is planning a multinational registration clinical trial for Central Retinal Artery Occlusion (CRAO) patients and has requested FDA orphan drug designation for KIO-401 in CRAO. As of September 30, 2026, Kiora's cash position was approximately $16.3 million, with a strategic focus on advancing KIO-401 and exploring next-generation calpain inhibitors.
QBTS
D-Wave Quantum Inc. has been recognized as a Market Shaper in the Gartner Emerging Market Quadrant for Quantum Computing - Established Vendors as of November 2026. This designation highlights the company's ability to deliver scalable fault-tolerant architectures, high-fidelity logical qubits, and enterprise quantum software stacks. CEO Dr. Alan Baratz notes that this recognition underscores D-Wave's transformative potential and its ongoing efforts to turn scientific breakthroughs into practical, scalable quantum computing solutions that deliver value.
HYPD
Hyperion DeFi, Inc. reported record Q3 2026 net income of $39.6 million, achieving breakeven core operating profit and cash flows one quarter ahead of its initial target. The company experienced a 127% quarter-over-quarter revenue increase and a 143% growth in adjusted gross profit, driven by scaling DeFi businesses. Legacy debt was retired, share repurchases commenced, and cash and cash equivalents rose by 31% quarter-over-quarter, with net cash from operations turning positive for the first time.
STDN
Standard Nuclear reported strong financial results for the third quarter of 2026, with total contract backlog more than doubling to $577.2 million and funded backlog nearly doubling to $119.6 million, reflecting increased demand for its TRISO nuclear fuel. The company completed the delivery of its first commercial reactor core to Radiant Industry, Inc., and executed fuel supply agreements with Antares Nuclear and Radiant, contributing to the growth in funded backlog and purchase options under executed contracts. Standard Nuclear also secured additional funding from the Department of Energy's ARPA-E office to develop TRISO fuel made with recycled transuranic material, selected by NASA for its Nuclear Thermal Propulsion program, further diversifying its revenue streams and expanding its capabilities in advanced nuclear fuel production.
FOXXW
Foxx Development Holdings Inc. agreed to issue 10.7 million shares of common stock to MMT E Buy Holdings Limited in a debt conversion agreement. The transaction, valued at $30 million, will satisfy the Subsidiary's accounts payable to the Creditor, contingent upon shareholder approval. The Creditor will release its claims against the Subsidiary upon closing, with remaining accounts payable unaffected.
AVAH
Aveanna Healthcare Holdings Inc. reported a robust third-quarter performance with revenue climbing 11.8% to $695.5 million and net income surging to $45.5 million, or 6.5% of revenue. Adjusted EBITDA for the quarter rose 25.0% to $100.1 million. The company also raised its 2026 revenue guidance to over $2.695 billion and Adjusted EBITDA to over $374 million, reflecting strong financial health and growth prospects.
KTB
Kontoor Brands, Inc. has entered into accelerated share repurchase agreements to buy back $400 million of its common stock, aligning with its strategy following the Lee business divestiture. The transactions, part of a $750 million authorization, involve an initial delivery of approximately 4.0 million shares, with the final share count determined by the volume-weighted average price during the agreement term, less a discount. Settlement is expected in the first half of 2027.
TE-WT
T1 Energy Inc. reported a net loss of $34.7 million for the third quarter ended September 30, 2026, with a loss per share of $(0.12). The company signed nearly 1.58GW of new offtake contracts, surpassing its targets, and built 1,056MW of modules at G1Dallas, marking its second-highest quarterly run-rate. T1 Energy also entered into a Letter of Intent to potentially monetize its Nordic Giga Arctic asset as a data center and received a waiver to import up to 1.725GW of solar cells, supporting its 2027 production guidance of 5.3GW.
FPS
Forgent Power Solutions, Inc. (NYSE: FPS) reported fiscal first quarter 2027 results, exceeding the high end of guidance ranges for revenues and Adjusted EBITDA. Revenues surged 69% year-over-year to $479 million, while Net Income soared 252% to $55 million, and Adjusted EBITDA increased 61% to $105 million. The company raised its full-year outlook, projecting 80% YoY revenue growth to $2,450-$2,650 million, with Adjusted EBITDA expected to grow 90% to $587-$637 million.
WWW
Wolverine Worldwide, Inc. reported strong third-quarter 2026 results, with segment revenue of $505.4 million, up 7.5% year-over-year, and adjusted diluted earnings per share of $0.79, up 119.4% year-over-year. The company raised its 2026 outlook, expecting revenue between $2.000 billion and $2.010 billion, with gross and operating margins of approximately 48.7% and 11.5%, respectively, benefiting from IEEPA tariff refunds. Balance sheet improvements included increased cash and reduced net debt by $143 million.
AIRO
AIRO Group Holdings, Inc. reported third-quarter 2026 results, showing revenue of $17.5 million, a 179% increase from the prior year, driven by strong growth in the Drones segment. Gross margin expanded to 57%, while operating and net losses narrowed, with cash reserves at $37.8 million and debt at $1.2 million. The company maintains a $200 million Drone backlog and a $1.5 billion opportunity pipeline, expecting to convert most of the backlog to revenue within 12 months, with full-year revenue growth projected at 15-25%.
ENGNW
EnGene Therapeutics Inc. updated its corporate and investor presentations, disclosing preliminary financials for the fiscal year ended October 31, 2026, with approximately $245.8 million in cash, cash equivalents, and marketable securities. The company announced pivotal Cohort 1 results from its Phase 2 LEGEND trial of detalimogene, aligning with the FDA on key Biologics License Application components. Management noted that forward-looking statements could be influenced by risks such as clinical development completion, regulatory timelines, and personnel recruitment and retention.
ECXJ
CXJ Group Co., Limited announced the resignation of J&S Associate PLT as its independent registered public accounting firm, effective immediately, due to material weaknesses in internal control over financial reporting. The Board approved the resignation and expressed gratitude for J&S's services. CXJ Group has appointed WSJ and Partners as its new independent registered public accounting firm for the fiscal year ending May 31, 2027, effective immediately.
MRMD
MariMed Inc. reported third quarter 2026 earnings with consolidated revenue reaching a record $44.2 million, reflecting a 5.5% sequential and 8.5% year-over-year increase. The company's adjusted EBITDA improved 18% sequentially to $4.7 million, while non-GAAP gross margin remained flat at 40% sequentially but declined approximately 140 basis points year-over-year. Wholesale and retail revenues grew 5.2% and 5.4% sequentially, respectively, with market share for branded products increasing 150 basis points across core markets.
IMXI
International Money Express, Inc. faces a potential acquisition termination by The Western Union Company due to regulatory hurdles. The merger, initially approved by the California Department of Financial Protection and Innovation (DFPI), was suspended on August 13, 2026, prompting Western Union to issue a termination notice on November 10, 2026. International Money Express contested the termination, citing Western Union's breach of obligations, and demanded the merger proceed, potentially through legal action. By November 11, 2026, Western Union withdrew its DFPI application, leaving the merger's future uncertain.
ENS
EnerSys reported second quarter fiscal 2027 results, achieving a gross margin of 29.9% and diluted EPS of $2.42, exceeding guidance. Net sales of $949.9 million were slightly below the prior year and guidance range, primarily due to foreign currency translation. The company returned $140 million to shareholders through share repurchases and dividends, maintaining EBITDA of $141.6 million and proposing an acquisition of Ultralife to expand battery technologies and accelerate growth in the defense market.
ATCHW
AtlasClear Holdings, Inc. faces imminent delisting from NYSE American due to the low selling price of its common stock, as announced on November 10, 2026. The company remains compliant with regulatory net capital requirements, and its clearing operations continue as usual. AtlasClearing, the subsidiary, has expanded its correspondent clearing relationships with eight new broker-dealer agreements. The common stock is expected to be quoted on the OTC market under the symbol "ATCH" during the appeal process, as the company seeks to reverse the delisting decision.
PXLW
Pixelworks, Inc. secured a multi-year device certification agreement with Meta for TrueCut Motion cinematic content and repurchased $1.2 million of common stock under its stock repurchase program. The company reported third-quarter 2026 revenue of $888 million, up from $400 million in the same period in 2025, with cash, cash equivalents, and short-term marketable securities totaling approximately $50 million. Despite a net loss from continuing operations of $10.14 million for the quarter, Pixelworks announced a conference call to discuss its financial results.
EYE
National Vision Holdings, Inc. reported robust third-quarter fiscal 2026 financial results, with net revenue rising 4.8% to $510.5 million and adjusted diluted EPS reaching $0.30. The company saw an 87.4% increase in adjusted operating income to $37.1 million, alongside a 3.5% growth in store count to 1,285 locations. National Vision updated its fiscal 2026 outlook, projecting adjusted comparable store sales growth of 2.0% to 3.0%, adjusted operating income of $119 million to $131 million, and adjusted diluted EPS of $0.95 to $1.03.
USDEW
StablecoinX Inc. announced it will release its third-quarter financial results for the period ending September 30, 2026, before the market opens on November 16, 2026, and will host a business update webcast on November 17, 2026. The company will provide updates on its Infrastructure Services, Infrastructure Software, and Distribution Services during the webcast. Shares of Class A common stock are listed on the Nasdaq under the symbol USDE, with warrants under USDEW, each exercisable for one share at $11.50 per share.
INVH
Invitation Homes Inc. expanded its board of directors from nine to ten members, appointing M. Colin Connolly, President and CEO of Cousins Properties Incorporated, as a director effective November 13, 2026. Connolly will serve on the Compensation and Management Development Committee and the Investment and Finance Committee, with a term expiring at the 2027 annual meeting. The appointment includes a $96,000 restricted stock unit award, vesting at the 2027 meeting, and Connolly will receive standard non-employee director compensation.
XE
X-Energy, Inc. reported third-quarter 2026 revenues and grant income of $66.3 million, up from $30.4 million in the same period in 2025. The company secured a construction permit from the Nuclear Regulatory Commission for Dow's Long Mott project in Texas, marking the first NRC approval for an advanced nuclear project site in the U.S. designed for industrial process heat. X-energy selected Fluor Corporation for nuclear engineering and design for the second Xe-100 project, announced procurement of steam generator components, and entered a Joint Development Agreement with American Electric Power for a proposed 960 MW SMR project in Indiana, supported by Amazon's funding.
SATA
Strive, Inc. increased the annual dividend rate on its Variable Rate Series A Perpetual Preferred Stock (SATA) to 13.25%, effective from December 1, 2026, and declared daily cash dividends of $0.0502 per share for December. Additionally, the company announced a 15.00% annual dividend rate on its Variable Rate Series A Perpetual SATS Preferred Stock (SATS), with daily dividends of $0.0569 per share for the same period.
AITX
Artificial Intelligence Technology Solutions, Inc. (AITX) has deployed a ROAMEO autonomous security robot for a 30-day proof of concept at a corrections facility. The initiative aims to assess ROAMEO's capabilities in autonomous perimeter patrols, reduce reliance on patrol vehicles, and extend the reach of officers on duty. The corrections operator, facing staffing shortages and heavy overtime demands, hopes this deployment could lead to broader use of ROAMEO units to enhance security and operational efficiency.
RLI
RLI Corp. declared a special cash dividend of $3.00 per share and a regular quarterly dividend of $0.18 per share, both payable on December 7, 2026, to shareholders of record as of November 30, 2026. The special dividend is expected to total approximately $275 million, reflecting the company's strong financial position. This move underscores RLI Corp.'s commitment to returning value to its shareholders.
RSKD
Riskified Ltd. reported a robust 41% year-over-year revenue growth to $115.2 million in Q3 2026, accelerating from 22% in the previous quarter, driven by new merchant acquisitions and upsell activities. The company's Digital Finance category surged over 300% year-over-year, while Electronics, General, and Home verticals collectively grew by 12%. Riskified launched Agent Identity Risk Intelligence and partnered with Zendesk to enhance customer service risk assessment, generating record free cash flow of $15.2 million and raising its full-year revenue guidance to $430 million at the midpoint.
CPAC
Cementos Pacasmayo S.A.A. received a subsequent Public Tender Offer (PTO) from Inversiones Aspi S.A., a subsidiary of Holcim Ltd., for its common voting shares and American Depositary Shares (ADS). The company addressed additional observations from the Superintendence of the Securities Market (SMV) by updating its informative prospectus and legal opinion. The revised documents will be accessible on the SMV's Single Digital Platform, the Lima Stock Exchange website, and through BBVA Bolsa Sociedad Agente de Bolsa S.A.
MOBBW
Mobilicom Limited has established its first U.S. manufacturing operations in Phoenix, Arizona, through a partnership with a U.S.-based contract manufacturer experienced in defense and aerospace. This move marks the company's initial step in expanding and onshoring production of its proprietary cybersecure datalink product family, with domestically manufactured products expected by year-end 2026. The initiative aims to expand production capacity, shorten delivery lead times, and align with U.S. federal procurement and NDAA requirements.
ASND
Ascendis Pharma A/S reported third-quarter 2026 financial results, showing a significant year-over-year increase in total product revenue to €366 million, up 89% from €213 million in the same period in 2025. The growth was primarily driven by YORVIPATH global sales, which reached €291 million, up 103% YoY. The company received positive opinions from the European Medicines Agency for TransCon CNP and SKYTROFA, with final decisions expected in Q4 2026 and Q1 2027, respectively.
AGQPF
Algonquin Power & Utilities Corp. has initiated consent solicitations for three series of subordinated notes, seeking approval for amendments to delete the Automatic Conversion feature. The amendments would allow note holders to retain their notes as subordinated debt instead of converting to preferred shares during bankruptcy and insolvency events. If approved, holders will not receive a consent payment, contingent on the amendments' implementation.
BAK
Braskem S.A. disclosed a default on its R$1.2 billion 18th issuance of debentures, due on November 9, 2026, and subsequently filed for extrajudicial reorganization on August 24, 2026. The 2nd Bankruptcy and Judicial Reorganization Court of São Paulo granted a 120-day stay on August 27, 2026. The company is committed to a consensual restructuring of its capital structure while maintaining operational continuity.
CLBT
Cellebrite DI Ltd. reported third-quarter 2026 results with total Annual Recurring Revenue (ARR) of $528.5 million, up 20% year-over-year, and a recurring revenue dollar-based net retention rate of 116%. Revenue for the quarter was $149.0 million, up 18% year-over-year, with Non-GAAP net income at $45.6 million. The company announced plans to redomicile in the United States to enhance growth opportunities and highlighted the availability of its agentic AI solution, Genesis, in key markets.
BNT
Brookfield Wealth Solutions reported strong third-quarter results, with distributable operating earnings of $1,445 million, up from $427 million in the prior year. Net income rose to $863 million from $608 million, driven by higher net investment income and improved underwriting results. The company completed a corporate simplification transaction, leading to the listing of Brookfield Corporation Ltd. shares on the NYSE and TSX under the symbol "BN" starting December 3, 2026, and maintained a robust liquidity position with $33 billion in cash and short-term investments.
AGBK
Agi Inc. reported robust third-quarter financial results for 2026, with Earnings Before Taxes (EBT) surging 62.8% year-over-year and Net Income climbing 37.8% to R$276.0 million. The company's active customer base expanded to 8.3 million, marking a record high, as it became the sixth-largest payer of INSS benefits in Brazil. Agi's credit portfolio captured an additional 40 basis points of market share in the INSS Payroll Credit segment, reaching 10.0%, and announced a share repurchase program of up to three million Class A shares.
BRPSF
Brookfield Corporation reported a 16% increase in earnings, with distributable earnings before realizations (DE) rising to $1.5 billion for the quarter ended September 30, 2026. The company repurchased approximately $300 million of shares, bringing total share repurchases to nearly $900 million for the year. Asset Management raised $25 billion of capital, positioning the fund to become the largest infrastructure fund globally, while Wealth Solutions saw a 22% increase in distributable earnings. Operating Businesses generated stable cash flows, with DE increasing by 14% to $467 million for the quarter.
CANF
Can-Fite BioPharma Ltd. announced promising preclinical results for its investigational compound piclidenoson (IB-MECA), showing up to 80% improvement in a kidney disease marker for Lowe syndrome. The research, published in Signal Transduction and Targeted Therapy, demonstrated piclidenoson's potential to correct cellular abnormalities and improve kidney function through activation of the A3 adenosine receptor. A Phase II clinical study is under review by Italian Health Authorities to evaluate the compound's efficacy and safety in adult patients with Lowe syndrome.
BMR
Beamr Imaging Ltd. reported a projected 50% revenue growth for 2026, reaching approximately $4.5 million, driven by customer agreements and a three-year renewal with a major global streaming platform. The company's strategy centers on Beamr Lossless, a GPU-accelerated compression technology, particularly targeting the autonomous vehicle market. Beamr aims to enhance technology adoption and convert engagements into production customers, focusing on commercial execution to boost future revenues.
MSLE
Sateillos Bioscience Inc. reported a significant increase in total assets to $57.98 million as of September 30, 2026, up from $31.89 million a year earlier. Total liabilities rose to $8.36 million, while shareholders' equity improved to $49.62 million, indicating a positive equity trend. Despite a net loss of $32.65 million for the nine months ended September 2026, the company issued $47.25 million in common shares and $4.65 million in Pre-funded Warrants, reflecting strategic capital-raising efforts.
CDROW
Codere Online reported robust third-quarter 2026 results, with revenue reaching €62.6 million, up 31%, and adjusted EBITDA climbing 45% to €4.2 million. The company's gaming win increased by 30% to €67.1 million, driven by a 13% rise in Spain revenue to €24.8 million and a 37% surge in Mexico revenue to €32.9 million. Codere Online also became the Official Betting Partner of the NFL in Mexico, reinforcing its market position.
CHA
Chagee Holdings Limited declared a special cash dividend of approximately US$1.95 per ordinary share or ADS, payable on December 4, 2026, to shareholders of record as of November 23, 2026. The Board approved this dividend as part of efforts to enhance shareholder value and also established a three-year annual dividend policy, committing to distribute at least 50% of net income from the financial year ending December 31, 2027. As of June 30, 2026, Chagee held approximately US$967.9 million in cash and cash equivalents.
PBR-A
Petrobras agreed to acquire the remaining 70% stake in Logum Logística S.A. from Raízen Energia S.A., Copersucar S.A., and Uniduto Logística S.A. for R$ 620 million, payable in three installments, making Petrobras the sole owner. This acquisition supports Petrobras' expansion into renewable and low-carbon energy, enhancing logistics efficiency and reducing emissions intensity, pending regulatory approval from Brazil's CADE.
NTPIF
Nam Tai Property Inc. reported a significant revenue decline in Q3 2026, falling to $5.1 million from $9.7 million in Q3 2025, primarily due to reduced property income and lower selling prices amid challenging market conditions. The company's cost of revenue decreased to $3.2 million from $6.7 million, reflecting lower sales volumes. Nam Tai Property Inc. maintains a stable financial position with total assets of $471.8 million, a current ratio of 1.14, and a debt ratio of 61.9%, despite the revenue drop.
KGEI
Kolibri Global Energy Inc. reported successful early results from its False Caney well in Oklahoma, averaging 636 barrels of oil equivalent per day, including 545 barrels of oil per day. The company installed tubing in the three Clifton Mack wells, achieving a combined rate of about 1,911 barrels of oil equivalent per day, including 720 barrels of oil per day. These wells are expected to add to proved reserves in the next report, with the company optimistic about future drilling locations enhancing reserves and shareholder value.
ALLT
Allot Ltd. reported strong revenue growth of 16% year-over-year to $30.6 million for the third quarter of 2026, with SECaaS revenues increasing 37% to $9.9 million. The company announced a GAAP operating income of $2.8 million and a non-GAAP operating income of $3.9 million, alongside an 85% increase in operating cash flow to $7.4 million. Cash and cash equivalents rose to $112 million, and Allot raised its 2026 revenue guidance midpoint to between $116 million and $118 million, expecting SECaaS revenue growth to exceed 40%.
PHTCF
PLDT Inc. faces imminent delisting from the New York Stock Exchange due to non-compliance with timely filing requirements for annual reports on Form 20-F for fiscal years 2024 and 2025. The withdrawal of audit opinions by SyCip Gorres Velayo & Co. contributed to the filing delinquency. PLDT has until February 13, 2027, to submit the delayed filings, with potential suspension and delisting procedures if unmet. The company plans to file as soon as practicable, and operations or the listing of its American Depositary Shares remain unaffected.
GLPGF
Lakefront Biotherapeutics NV reported a significant decrease in total net revenues for the first nine months of 2026, dropping from €211.4 million in 2025 to €26.1 million, primarily due to the sale of its early-stage cell therapy pipeline to Armed Cell Therapeutics BV for €8 million upfront, with potential milestone payments of up to €230 million. The company's cost of sales decreased by 40%, and R&D expenses dropped by 77%, reflecting the wind-down of its cell therapy activities. Lakefront Biotherapeutics NV completed a €50 million share repurchase program and initiated a second €50 million program, while appointing Dr. Mehdi Shahidi as a Non-Executive Independent Board Director.
AKZOF
Akzo Nobel N.V. and Axalta Coating Systems Ltd. are addressing the UK Competition and Markets Authority's (CMA) Phase 1 decision on their proposed merger, which identified competition concerns in the UK vehicle refinish (VR) coatings market. The companies have agreed with the European Commission on a remedy package involving the divestment of Akzo Nobel's European VR coatings business, including its UK operations. They remain confident that the merger, expected to create a global coatings company with approximately $17 billion in revenue, will be completed by early 2027.
CLGN
CollPlant Biotechnologies Ltd. announced its subsidiary LightSolver Ltd. will unveil the first public demonstration of its all-optical Laser Processing Unit (LPU) at SC26 in Chicago, November 15-20, 2026. The LPU, designed to process mathematical problems using light, will be showcased at booth 5102 from November 16-19. Additionally, LightSolver will present Boeing corrosion-simulation work and participate in a session based on the U.S. Department of Energy report. The company plans to change its name to OptiPhi Computing Ltd. and its Nasdaq ticker symbol from "CLGN" to "OPHI," pending shareholder and Nasdaq approval.
ESLT
Elbit Systems Ltd. secured a $260 million contract to supply Precise & Universal Launching System (PULS) rocket artillery systems and munitions to a European NATO member country. The five-year contract underscores Elbit's role in supporting major defense modernization programs and highlights its long-term partnerships with European customers. The PULS system offers a comprehensive solution adaptable to various platforms, promising reduced maintenance and training costs.
GMTL
Guardian Metal Resources PLC announced its strategic spin-out of its non-tungsten exploration portfolio into a new company, Spin-Co, targeting AIM admission by Q2 2027. The spin-off will include projects like Garfield, Golconda Summit, and Stonewall in Nevada, while Guardian Metal retains its tungsten-focused assets such as Pilot Mountain and Tempiute. This move aims to enhance focus on core tungsten projects, allowing for independent valuation of non-core assets and maintaining shareholder exposure to Spin-Co.
NFGC
New Found Gold Corp. achieved commercial production at its Hammerdown Gold Mine, generating $41.6 million in Q3 2026 revenue from 6,935 ounces of gold. The mine produced 4,863 ounces at an average grade of 2.77 g/t Au, with a recovery rate of 84.2%. Despite a net loss of $7.1 million, EBITDA improved to $13.1 million, and the company maintained a strong cash position of $167.1 million.
ADXN
Neurosterix secured $105 million in Series B financing from leading life science investors, excluding Addex Therapeutics, whose equity interest now stands at 8.5% of issued capital, valued at $18.6 million. The funds will primarily support the Phase 2 clinical development of NTX-253 for schizophrenia and expand Neurosterix's pipeline of selective allosteric modulators for neuropsychiatric disorders. This financing underscores the potential of the allosteric approach in treating such conditions.
XNDU
Xanadu Quantum Technologies Limited reported a third-quarter 2026 loss of $32.2 million, up from $20.3 million in the same period last year. The company achieved a new 7-millidecibel optical switch record and announced manufacturing partnerships with ASML, Bluefors, and GlobalFoundries. Revenue increased by 32% to $1.3 million, driven by DARPA QBI revenue and partnerships, while R&D expenses rose by 67% to $25.6 million.
CSTE
Caesarstone Ltd. reported third-quarter 2026 financial results, including revenue of $96.3 million and a net loss of $56.1 million, primarily due to a $46.8 million California jury verdict. The company achieved near breakeven adjusted EBITDA, reflecting optimized production and cost savings, with gross margin improving to 25.4% year-over-year. Operating expenses were $81.4 million, or 84.6% of revenue, as Caesarstone continues to monitor U.S. tariffs impacting its 40% U.S. market share.
HXHX
Haoxin Holdings Limited announced the rescheduled extraordinary general meeting (EGM) for November 14, 2026, to adopt an amended and restated memorandum and articles of association, and to approve two share consolidation proposals. The First Share Consolidation and the Conditional Second Share Consolidation aim to increase the company's authorized share capital from US$50,000 to US$90,000, adjusting the number of Class A and Class B ordinary shares and their par value. The Conditional Second Share Consolidation depends on the First Share Consolidation's effectiveness and the Class A closing bid price on Nasdaq being US$1.25 or below.
OR
OR Royalties Inc. reported a significant increase in total assets, rising from $147,684 thousand in September 2026 to $1,891,381 thousand in December 2025, driven by growth in investments and royalty interests. The company's liabilities also increased, with current liabilities growing from $32,632 thousand to $134,438 thousand, primarily due to a rise in long-term debt. OR Royalties Inc.'s revenues surged from $71,625 thousand in the three months ended September 2026 to $186,905 thousand in the nine months ended September 2026, with operating income climbing to $230,713 thousand in the same period.
FNV
Franco-Nevada Corporation reported Q3 2026 results, showing a 13% revenue increase to $549.3 million, driven by stronger gold and oil prices. The company generated $429.2 million in operating cash flow, a 23% increase, and $493.9 million in Adjusted EBITDA, a 15% increase. Year-to-date 2026 results showed a 45% revenue increase to $1,780.9 million and a 64% net income increase to $1,218.1 million. The company also announced portfolio additions, including a royalty agreement with Discovery Mining Ltd. and a financing package with Minerals 260 Limited for the Bullabulling Gold Project in Australia.
VLN-WT
Valens Semiconductor Ltd. reported robust third-quarter 2026 results, with revenue of $21.9 million, surpassing guidance, and gross margins of 62.2% GAAP and 64.4% non-GAAP. The company launched the VS6310 low-power USB3 extension chipset for e/PTZ cameras and announced a strategic collaboration with onsemi for automotive camera applications. Valens' automotive revenue accounted for 35% of total revenue, while cross-industry business revenue comprised 65%, with full-year guidance reaffirmed at $78-$81 million in revenue and adjusted EBITDA losses of $(14.9) million to $(12.9) million.
RDCM
RADCOM Ltd. reported a 19.4% sequential revenue increase to $14.0 million in the third quarter of 2026, achieving non-GAAP operating profitability after a GAAP operating loss of $0.9 million. The company maintained positive cash flow of $1.7 million, boosting cash reserves to $111.4 million with no debt. RADCOM secured new contracts with VNPT and CETIN Networks, authorized a $20 million share repurchase program, and reaffirmed its investment in RADCOM ACE and its agentic AI roadmap.
CMDB
Costamare Bulkers Holdings Limited reported strong third-quarter financial results for 2026, with net income of $16.6 million and adjusted net income of $12.4 million. The company's balance sheet shows $141.7 million in cash, exceeding debt by $358.2 million, with no significant loan maturities until Q4 2031. Costamare Bulkers has secured $133 million in new loan facilities, refinancing existing obligations, reducing costs, and extending debt maturities to Q4 2031 or Q1 2032, while increasing its unencumbered fleet from 3 to 11 vessels.
ECO
Okeanis Eco Tankers Corp. reported significant financial improvements for the third quarter and nine-month period of 2026 compared to 2025. For Q3 2026, revenues surged to $501.5 million from $90.6 million, with profits rising to $299.6 million from $24.1 million. In the nine-month period ending September 30, 2026, revenues reached $990.5 million from $264.7 million, and profits grew to $618.2 million from $63.5 million. The company also noted increased cash flow, with cash holdings rising to $233.1 million as of September 30, 2026, from $122.5 million as of December 31, 2025.
MGA
Magna International Inc. announced new mid-term financial targets, aiming for 2-4% above-market organic sales growth annually through 2030, and an adjusted EBIT margin improvement of over 200 basis points from 2026 to 2030. The company projects at least 15% compound annual growth in adjusted EPS through 2030, with a free cash flow conversion of at least 85% on adjusted net income for 2027-2030, and an adjusted ROIC greater than 15% by 2030. Magna has solid visibility into its growth, with over 90% of expected 2028 sales and more than 60% of 2030 sales supported by existing business and awarded programs.
Pre-Market Options Data
